Market Overview:
The global women's health diagnostics market reached a value of US$ 21.62 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 35.7 Billion by 2027, exhibiting at a CAGR of 8.10% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Women's health diagnostics help diagnose various biological and psychosocial conditions of female patients. They assist in addressing sexual and vaginal issues and pregnancy complications and managing threatening diseases, such as osteoporosis, menopause, and certain cancers like breast and cervical. They rely on a series of advanced laboratory tests, tools, and procedures, which include biopsy, ultrasound, chemotherapy, and magnetic resonance imaging (MRI). Several healthcare diagnostics centers are currently offering an expansive range of laboratory testing solutions to enhance the diagnosis and management of rare diseases and conditions that affect women.
Women's Health Diagnostics Market Trends:
The rising prevalence of health issues that impact the overall well-being of women represents one of the major factors influencing the market positively. Moreover, the growing health consciousness, along with the increasing awareness about the benefits of early diagnosis, is catalyzing the demand for point-of-care (POC) women’s health diagnostics across the globe. Apart from this, the rising rate of infertility on account of stressful lifestyles and the growing consumption of alcohol and drugs is driving the need for women’s health diagnostics to address pregnancy complications and ensure a healthier life. Furthermore, as menopause can increase the risk of developing certain medical conditions, including cardiovascular diseases and urinary incontinence, a significant rise in the female population which is over 50 years is contributing to the market growth. Besides this, several research studies have concluded that women are more likely to experience psychiatric disorders, such as depression and anxiety, during hormonal changes. This, in confluence with several initiatives undertaken by health agencies of numerous countries to improve mental health of women, is propelling the market growth across the globe.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global women's health diagnostics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, application and end user.
Breakup by Type:
- Diagnostic Devices
- Biopsy Device
- Imaging and Monitoring Devices
- Accessories and Consumables
- Diagnostic Tests
- Breast Cancer Testing
- PAP Smear and HPV Test
- Pregnancy Testing and Ovulation Testing
- Others
Breakup by Application:
- Breast Cancer
- Infectious Disease Testing
- Osteoporosis Testing
- Pregnancy and Fertility Testing
- Sexually Transmitted Disease Testing
- Others
Breakup by End User:
- Hospital and Diagnostics Centers
- Home Care
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Cardinal Health Inc., Cook Group Incorporated, F. Hoffmann-La Roche AG, General Electric Company, Hologic Inc., Koninklijke Philips N.V., Perkinelmer Inc., Quest Diagnostics Inc., Siemens AG and Thermo Fisher Scientific Inc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Type, Application, End User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Cardinal Health Inc., Cook Group Incorporated, F. Hoffmann-La Roche AG, General Electric Company, Hologic Inc., Koninklijke Philips N.V., Perkinelmer Inc., Quest Diagnostics Inc., Siemens AG and Thermo Fisher Scientific Inc. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global women's health diagnostics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global women's health diagnostics market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global women's health diagnostics market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Women's Health Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Diagnostic Devices
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Biopsy Device
6.1.2.2 Imaging and Monitoring Devices
6.1.2.3 Accessories and Consumables
6.1.3 Market Forecast
6.2 Diagnostic Tests
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Breast Cancer Testing
6.2.2.2 PAP Smear and HPV Test
6.2.2.3 Pregnancy Testing and Ovulation Testing
6.2.2.4 Others
6.2.3 Market Forecast
7 Market Breakup by Application
7.1 Breast Cancer
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Infectious Disease Testing
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Osteoporosis Testing
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Pregnancy and Fertility Testing
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Sexually Transmitted Disease Testing
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by End User
8.1 Hospital and Diagnostics Centers
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Home Care
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Becton Dickinson and Company
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 bioMérieux SA
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Cardinal Health Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Cook Group Incorporated
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 F. Hoffmann-La Roche AG
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 General Electric Company
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Hologic Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Koninklijke Philips N.V.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Perkinelmer Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Quest Diagnostics Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Siemens AG
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
14.3.13 Thermo Fisher Scientific Inc.
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis
List of Figures
Figure 1: Global: Women's Health Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Women's Health Diagnostics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Women's Health Diagnostics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Women's Health Diagnostics Market: Breakup by Type (in %), 2021
Figure 5: Global: Women's Health Diagnostics Market: Breakup by Application (in %), 2021
Figure 6: Global: Women's Health Diagnostics Market: Breakup by End User (in %), 2021
Figure 7: Global: Women's Health Diagnostics Market: Breakup by Region (in %), 2021
Figure 8: Global: Women's Health Diagnostics (Diagnostic Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Women's Health Diagnostics (Diagnostic Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Women's Health Diagnostics (Diagnostic Tests) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Women's Health Diagnostics (Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Women's Health Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Women's Health Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Women's Health Diagnostics (Infectious Disease Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Women's Health Diagnostics (Infectious Disease Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Women's Health Diagnostics (Osteoporosis Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Women's Health Diagnostics (Osteoporosis Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Women's Health Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Women's Health Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Women's Health Diagnostics (Home Care) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Women's Health Diagnostics (Home Care) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: North America: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: North America: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: United States: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: United States: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Canada: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Canada: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Asia-Pacific: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Asia-Pacific: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: China: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: China: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Japan: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Japan: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: India: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: India: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: South Korea: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: South Korea: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Australia: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Australia: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Indonesia: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Indonesia: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Others: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Europe: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Europe: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Germany: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Germany: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: France: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: France: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: United Kingdom: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: United Kingdom: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Italy: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Italy: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Spain: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Spain: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Russia: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Russia: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Others: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Latin America: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Latin America: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Brazil: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Brazil: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Mexico: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Mexico: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Middle East and Africa: Women's Health Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Middle East and Africa: Women's Health Diagnostics Market: Breakup by Country (in %), 2021
Figure 76: Middle East and Africa: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Global: Women's Health Diagnostics Industry: SWOT Analysis
Figure 78: Global: Women's Health Diagnostics Industry: Value Chain Analysis
Figure 79: Global: Women's Health Diagnostics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Women's Health Diagnostics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Women's Health Diagnostics Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Women's Health Diagnostics Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Women's Health Diagnostics Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Women's Health Diagnostics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Women's Health Diagnostics Market: Competitive Structure
Table 7: Global: Women's Health Diagnostics Market: Key Players